Korea Drug Development Fund to conclude joint anticancer R&D agreement

Published: 2016-06-10 11:20:19

Updated: 2016-06-10 11:20:33

The Korea Drug Development Fund(Head Sang-Un Joo, hereinafter referring to KDDF) will start the ‘BigPharma Joint R&D Program’ in regards of anticancer development researches.

On the 8^th, the KDDF announced it concluded the MOU to operate the joint R&D program with a global pharmaceutical company, MSD, in the afternoon of the 7^th at San Francisco Marriott Marquis where the 2016 BIO Internation...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.